Literature DB >> 2112574

Cellular and humoral immune responses to Plasmodium falciparum gametocyte antigens in malaria-immune individuals. Limited response to the 48/45-kilodalton surface antigen does not appear to be due to MHC restriction.

E M Riley1, C S Ong, O Olerup, S Eida, S J Allen, S Bennett, G Andersson, G A Targett.   

Abstract

We have examined immune responses to a cultured Plasmodium falciparum gametocyte lysate and to an affinity-purified preparation of the 48/45-kDa gamete surface Ag in a group of 30 malaria immune individuals and in 24 Europeans with no previous exposure to malaria. Cellular responses were assessed in vitro by lymphoproliferation and production of IFN-gamma; antigamete antibodies were detected by immunofluorescence, Western blotting, and competitive ELISA. Cells from all the malaria immune donors responded to the gametocyte lysate in both assays while cells from nonimmune donors gave only weak proliferative responses. Antigamete antibodies were detected in the serum of all the immune donors but not in serum from nonimmunes. Nonimmune donors were completely unresponsive to the purified 48/45-kDa surface Ag while cells from 40% of immune donors responded by either proliferation or IFN-gamma production. Only 3 of 30 immune donors had detectable antibodies to the 48/45-kDa Ag. Class II HLA type was determined for 27 of the immune donors but no relationship between HLA-DR or -DQ and responsiveness to the 48/45-kDa Ag was discerned. The possible reasons for limited recognition of this gamete surface Ag are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112574

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens.

Authors:  A Jepson; W Banya; F Sisay-Joof; M Hassan-King; C Nunes; S Bennett; H Whittle
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Plasmodium falciparum gametocyte adhesion to C32 cells via CD36 is inhibited by antibodies to modified band 3.

Authors:  N J Rogers; G A Targett; B S Hall
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Lymphocyte response in vitro to Plasmodium falciparum merozoite antigens in donors from a holoendemic area.

Authors:  A Dieye; H G Heidrich; C Rogier; J F Trape; P Launois; A A Holder; J L Sarthou
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

4.  CD36 and intercellular adhesion molecule 1 mediate adhesion of developing Plasmodium falciparum gametocytes.

Authors:  N J Rogers; O Daramola; G A Targett; B S Hall
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

5.  H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.

Authors:  D M Banic; P Delplace; C Mazingue; D Camus
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

6.  Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.

Authors:  J Healer; D McGuinness; P Hopcroft; S Haley; R Carter; E Riley
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells.

Authors:  N J Rogers; B S Hall; J Obiero; G A Targett; C J Sutherland
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 8.  Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.

Authors:  Charles Mulamba; Chris Williams; Katharina Kreppel; Jean Bosco Ouedraogo; Ally I Olotu
Journal:  Malar J       Date:  2022-06-02       Impact factor: 3.469

9.  Genetic regulation of human anti-malarial antibodies in twins.

Authors:  K Sjöberg; J P Lepers; L Raharimalala; A Larsson; O Olerup; N T Marbiah; M Troye-Blomberg; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.

Authors:  Andres F Vallejo; Nora L Martinez; Alejandra Tobon; Jackeline Alger; Marcus V Lacerda; Andrey V Kajava; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Malar J       Date:  2016-04-12       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.